CHAPEL HILL, N.C.--(BUSINESS WIRE)--July 25, 2006--POZEN Inc.
(NASDAQ: POZN) announced today that it will release second quarter
2006 results on August 3, 2006, before the market opens.
The announcement will be followed by a live webcast at 11:00 a.m.
Eastern Time with a discussion by POZEN management of the financial
and business results. The webcast can be accessed on POZEN's website
at www.pozen.com and will be archived and available for replay. The
second quarter 2006 earnings release can be accessed in the News
section of POZEN's website.
POZEN is a pharmaceutical company committed to developing
therapeutic advancements for diseases with unmet medical needs where
it can improve efficacy, safety, and/or patient convenience. POZEN
focuses its efforts primarily on the development of pharmaceutical
products for the treatment of acute and chronic pain and other
pain-related conditions. POZEN has a development and commercialization
alliance with GlaxoSmithKline. The company's common stock is traded on
The Nasdaq Stock Market under the symbol "POZN". For detailed company
information, including copies of this and other press releases, see
POZEN's website: www.pozen.com.
CONTACT: POZEN Inc.
Bill Hodges, Chief Financial Officer, 919-913-1030
Fran Barsky, Director, Investor Relations, 919-913-1044
SOURCE: POZEN Inc.